121 related articles for article (PubMed ID: 1662376)
1. [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation].
Pouteil-Noble C; Bétuel H; Raffaele P; Megri K; Louvier C; Lefrançois N; Bosshard S; Dubernard JM; Aymard M; Touraine JL
Presse Med; 1991 Nov; 20(40):2022-4. PubMed ID: 1662376
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
3. CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.
Mikulska M; Raiola AM; Bruzzi P; Varaldo R; Annunziata S; Lamparelli T; Frassoni F; Tedone E; Galano B; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2012 Jan; 18(1):92-9. PubMed ID: 21689774
[TBL] [Abstract][Full Text] [Related]
4. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease.
Blancho G; Josien R; Douillard D; Bignon JD; Cesbron A; Soulillou JP
Transplantation; 1992 Nov; 54(5):871-4. PubMed ID: 1332224
[TBL] [Abstract][Full Text] [Related]
5. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
[TBL] [Abstract][Full Text] [Related]
6. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603
[TBL] [Abstract][Full Text] [Related]
7. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.
Pouteil-Noble C; Ecochard R; Landrivon G; Donia-Maged A; Tardy JC; Bosshard S; Colon S; Betuel H; Aymard M; Touraine JL
Transplantation; 1993 Apr; 55(4):851-7. PubMed ID: 8386406
[TBL] [Abstract][Full Text] [Related]
9. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
Bućin D
Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
[TBL] [Abstract][Full Text] [Related]
10. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients.
Morris DJ; Martin S; Dyer PA; Hunt L; Mallick NP; Johnson RW
J Med Virol; 1993 Dec; 41(4):324-7. PubMed ID: 8106868
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
[TBL] [Abstract][Full Text] [Related]
12. HLA compatibility index: does it have a role in patients after heart transplantation?
Bedanova H; Orban M; Ondrasek J; Stepanova R; Nemec P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):5-11. PubMed ID: 23446213
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
Du J; Liu J; Gu J; Zhu P
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
[TBL] [Abstract][Full Text] [Related]
14. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
Szymczakiewicz-Multanowska AM; Kuźniewski M; Zawilińska B; Zgórniak-Nowosielska I; Uracz D; Ignacak E; Betkowska-Prokop A; Sułowicz W
Przegl Lek; 2001; 58(7-8):772-7. PubMed ID: 11769385
[TBL] [Abstract][Full Text] [Related]
15. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
[TBL] [Abstract][Full Text] [Related]
16. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection.
van Es A; Baldwin WM; Oljans PJ; Tanke HJ; Ploem JS; van Es LA
Transplantation; 1984 Jan; 37(1):65-9. PubMed ID: 6320508
[TBL] [Abstract][Full Text] [Related]
19. Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival.
Krishnan G; Vaughn WK; Capelli JP; Glass NR
Transplant Proc; 1993 Feb; 25(1 Pt 2):1485-6. PubMed ID: 8382877
[No Abstract] [Full Text] [Related]
20. The impact of HLA-DR incompatibilities on kidney graft function and on the number of rejection treatments. The Dutch Study Group of Renal Transplantation.
Groenewoud AF
Transplant Proc; 1987 Feb; 19(1 Pt 1):683-4. PubMed ID: 3274840
[No Abstract] [Full Text] [Related]
[Next] [New Search]